Showing results (711-720 of 838) with videos related to

Sort By:
Pageof 84
Epidemiology and Infection|April 24, 2020
Experiential learnings from the Nipah virus outbreaks in Kerala towards containment of infectious public health emergencies in IndiaRima R Sahay, Pragya D Yadav, Nivedita Gupta, et al.
JAMA Network Open|October 4, 2021
Differences in Breast and Colorectal Cancer Screening Adherence Among Women Residing in Urban and Rural Communities in the United StatesSanjay Shete, Yangyang Deng, Jackilen Shannon, et al.
Comparative Immunology, Microbiology and Infectious Diseases|April 7, 2022
Serosurvey for Nipah virus in bat population of southern part of IndiaMangesh Gokhale, A B Sudeep, Basavaraj Mathapati, et al.
Scientific Reports|July 30, 2020
Study of Kyasanur forest disease viremia, antibody kinetics, and virus infection in target organs of Macaca radiataDilip R Patil, Pragya D Yadav, Anita Shete, et al.
Human Vaccines & Immunotherapeutics|December 28, 2022
Evaluation of immunogenicity post two doses of inactivated SARS-CoV-2 vaccine, Covaxin after six monthsRima R Sahay, Pragya D Yadav, Ashok Nandapurkar, et al.
Breast (Edinburgh, Scotland)|September 25, 2024
Financial toxicity in breast cancer patients receiving regional nodal irradiation: Variation by cancer subtypeGrace L Smith, Benjamin D Smith, Chi-Fang Wu, et al.
Journal of Medical Virology|September 16, 2024
Comparative immune profiling in survivors of the 2023 Nipah outbreak in Kerala state, IndiaRima R Sahay, Harsha C Palav, Anita M Shete, et al.
Eclinicalmedicine|December 11, 2024
Impact of a multicomponent strategy including decentralized molecular testing for tuberculosis on mortality: planned analysis of a cluster-randomized trial in UgandaAchilles Katamba, Tessa Mochizuki, Talemwa Nalugwa, et al.
Plos One|February 19, 2013
Safety and immunogenicity of DNA and MVA HIV-1 subtype C vaccine prime-boost regimens: a phase I randomised Trial in HIV-uninfected Indian volunteersSanjay Mehendale, Madhuri Thakar, Seema Sahay, et al.
Cureus|March 16, 2026
Hypertension Management Beyond Blood Pressure Control in India: An Expert Consensus on Angiotensin II Receptor Blocker and Calcium Channel Blocker Combination Therapy With Reference to Telmisartan and CilnidipineJagdish Hiremath, Ashok Kirpalani, Deodatta Chafekar, et al.
Pageof 84